Patent · US Active

Anti-VEGF-C antibodies and methods using same

US8486397B2 · kind B2 · utility

11Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2010
Grant dateJul 16, 2013
Priority date—
Expiry dateAug 16, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides VEGF-C antagonists, such as anti-VEGF-C antibodies, and their use in the prevention and treatment of tumor progression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.